Koji N. is an accomplished professional with extensive experience in corporate strategy and management. Currently serving as Corporate Officer and Head of the Corporate Planning Department at （株）新日本科学 since June 2025, Koji previously held the position of Director at the Sales Department of Sansan株式会社 from August 2019 to May 2025. Prior consulting experience includes a role at Arthur D. Little from October 2018 to July 2019, and a significant tenure as Product Manager at MISUMI Group Inc. from October 2011 to September 2018. Koji N. holds a Master of Business Administration (MBA) from the University of Michigan and a Bachelor's degree in Political Science from Keio University.
This person is not in any teams
This person is not in any offices
Shin Nippon Biomedical Laboratories Ltd
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.